Article Text

PDF
Congenital heart disease
Outcomes in patients with pulmonary hypertension undergoing percutaneous atrial septal defect closure
  1. O H Balint1,2,
  2. A Samman1,
  3. K Haberer1,
  4. L Tobe1,
  5. P McLaughlin1,
  6. S C Siu1,
  7. E Horlick1,
  8. J Granton1,
  9. C K Silversides1
  1. 1
    Toronto Congenital Cardiac Centre for Adults, University of Toronto, University Health Network, Toronto, Canada
  2. 2
    Gottsegen Gyorgy, Hungarian Institute of Cardiology, Budapest, Hungary
  1. Dr C K Silversides, Toronto General Hospital, 585 University Avenue, 5N-521 North Wing, Toronto, ON, Canada; candice.silversides{at}uhn.on.ca

Abstract

Objectives: To examine the outcomes in patients with moderate or severe pulmonary arterial hypertension (PAH) undergoing percutaneous atrial septal defect (ASD) closure.

Design: Retrospective study.

Setting: Teaching hospital-based study.

Patients: Fifty-four patients with moderate (n = 34) or severe PAH (n = 20) who underwent successful device implantation between 1999 and 2004 were included in the study. Clinical and transthoracic echocardiographic data were reviewed. Pulmonary hypertension was classified as moderate (50–59 mm Hg) or severe (⩾60 mm Hg) according with the right ventricular systolic pressure (RVSP) calculated by echocardiography.

Results: At the early follow-up (mean (SD) 2.3 (1.2) months) all patients were alive and the baseline RVSP decreased from 57 (11) mm Hg to 51 (17) mm Hg (p = 0.003). At the late follow-up (n = 39, mean (SD) duration 31 (15) months) two patients had died and the baseline RVSP decreased from 58 (10) mm Hg to 44 (16) mm Hg (p = 0.004). Although the overall mean RVSP decreased at late follow-up, only 43.6% (17/39) of patients had normalisation (<40 mm Hg) of the RVSP and 15.4% (6/39) had persistent severe PAH.

Conclusion: Transcatheter closure in patients with secundum ASD and PAH can be successfully performed in selected subjects and is associated with good outcomes. Early improvements in RVSP are seen in patients with moderate or severe PAH undergoing transcatheter ASD closure. Continued improvement in RVSP occurs in late follow-up. Despite decreases in the mean RVSP in late follow-up, many patients do not have complete normalisation of pressures.

Statistics from Altmetric.com

Footnotes

  • Funding: CKS is supported by a research grant from the Heart and Stroke Foundation of Canada (grant NA 5927).

  • Competing interests: None.

  • Ethics approval: Approved by the Toronto General Hospital’s research ethics board.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles